Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population
- PMID: 3149581
Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population
Abstract
The Comprehensive Epilepsy Program of Minnesota database was searched for patients who had no dose change of carbamazepine (CBZ), phenytoin (PHT) or valproate (VPA) for 3 consecutive visits. Data from 860 patients were available. The coefficient of variation (CV) was calculated from 3 or more visits without dose change. For CBZ, 290 CV values from 206 individuals were available; the mode CV was 23.3%. For PHT 293 CVs were collected from 192 individuals; the mode CV was 25.2%. For VPA 244 CVs was 181 persons; the mode CV was 27.1%. If one uses the standard of a CV of less than 20% representing compliance with PHT, and a CV of less than 25% for CBZ and VPA, it appears that even in a specialty clinic, compliance with medication is a significant problem.
Similar articles
-
Evaluation of therapeutic drug monitoring of antiepileptic drugs.Int J Clin Pharmacol Ther. 2003 Mar;41(3):126-31. Int J Clin Pharmacol Ther. 2003. PMID: 12665161
-
[The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate].Rev Neurol. 1999 Jun 1-15;28(11):1043-7. Rev Neurol. 1999. PMID: 10390769 Spanish.
-
[Combination therapy with carbamazepine and valproic acid in problem cases at an outpatient epilepsy clinic].Arzneimittelforschung. 1984;34(8):910-4. Arzneimittelforschung. 1984. PMID: 6437416 German.
-
The newer antiepileptic drugs: carbamazepine and valproic acid.Pediatr Ann. 1991 Jan;20(1):34-40. doi: 10.3928/0090-4481-19910101-10. Pediatr Ann. 1991. PMID: 2000232 Review. No abstract available.
-
Neurobehavioral effects of phenytoin, carbamazepine, and valproic acid: implications for use in traumatic brain injury.Arch Phys Med Rehabil. 1991 Mar;72(3):219-26. Arch Phys Med Rehabil. 1991. PMID: 1998458 Review.